Clinical Trial Update: Study to Evaluate SAGE-324 in Participants With Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SAGE-324 in participants with Essential Tremor has completed, and results were posted on 2025-05-16. This is a clinical trials update f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• SAGE-324 (SAGE-324)

Snippet

Sponsor: Sage Therapeutics | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2025-05-16